CRC cases with decreased CDX2 expression (p < 0.0001) and cases with the “stem-like” immunophenotype (p = 0.0027) showed significantly worse clinical outcomes (Supplementary Figure S2a,c). The gene discussed is CDX2; the disease is colorectal carcinoma.